Brian Helfand
Urology · Chicago, ILNPI 1851551782
Payments from drug & device makers
Across 554 payments — averaging $2093.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$499K
- Blue Earth Diagnostics$478K
- Angiodynamics, Inc.$104K
- Olympus Corporation Of The Americas$32K
- Astellas Pharma Global Development$28K
- Pfizer$12K
- plus $7K from 16 others
Across 4 payments — averaging $631.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astellas Pharma Global Development$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 380 | $498,723 |
| Blue Earth Diagnostics | 56 | $478,117 |
| Angiodynamics, Inc. | 34 | $103,862 |
| Olympus Corporation Of The Americas | 3 | $32,336 |
| Astellas Pharma Global Development | 4 | $27,680 |
| Pfizer | 8 | $11,909 |
| Janssen Scientific Affairs, LLC | 3 | $2,845 |
| Olympus America Inc. | 14 | $1,579 |
| Boston Scientific | 32 | $1,542 |
| Calyxo, Inc. | 2 | $280 |
| Laborie Medical Technologies Corp. | 1 | $136 |
| Dendreon Pharmaceuticals LLC | 1 | $122 |
| Antares Pharma, Inc. | 5 | $111 |
| Progenics Pharmaceuticals, Inc. | 2 | $65 |
| EDAP Technomed Inc | 1 | $56 |
| Johnson & Johnson | 1 | $33 |
| 180 Medical, Inc. | 2 | $32 |
| Urogen Pharma, Inc. | 1 | $31 |
| Photocure Inc | 1 | $30 |
| GE HealthCare | 1 | $30 |
| Neotract Inc. | 1 | $16 |
| AbbVie | 1 | $12 |
How this compares
$1,159,547 in reported general payments places this provider in the 95th percentile of 550 urology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Chicago
- Ashley RossChicago$2.3M
- Joshua MeeksChicago$2M
- Courtney HollowellChicago$1.9M
- Gary SteinbergChicago$1.4M
- Simone CrivellaroChicago$1.1M
- Michael AbernChicago$1M
- Roohollah SharifiChicago$828K
- Amy KrambeckChicago$700K
- Srinivas VourgantiChicago$297K
- Kevin ZornChicago$274K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.